Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2003-02-13
2009-06-16
Borin, Michael (Department: 1631)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600, C530S350000, C530S345000, C424S280100
Reexamination Certificate
active
07547675
ABSTRACT:
The present invention relates to a chemically modified polypeptide in which at least one of hydroxyl groups in the polypeptide molecule is modified with a polyalkylene glycol derivative; a method for producing the modified polypeptide; a method of treatment using the modified polypeptide; use of the modified polypeptide; a pharmaceutical preparation comprising the modified polypeptide; and a composition for treatment comprising the modified polypeptide.
REFERENCES:
patent: 4732863 (1988-03-01), Tomasi et al.
patent: 5081111 (1992-01-01), Akimoto et al.
patent: 5153265 (1992-10-01), Shadle et al.
patent: 5194592 (1993-03-01), Yoshida
patent: 5342940 (1994-08-01), Ono et al.
patent: 5359030 (1994-10-01), Ekwuribe
patent: 6433135 (2002-08-01), El-Tayar et al.
patent: 6583267 (2003-06-01), Yamasaki et al.
patent: 6884419 (2005-04-01), Yokoi et al.
patent: 1150434 (1997-05-01), None
patent: 335423 (1989-10-01), None
patent: 400472 (1990-12-01), None
patent: 0 744 409 (1996-11-01), None
patent: 62-501449 (1987-06-01), None
patent: 1-316400 (1989-12-01), None
patent: 3-95200 (1991-04-01), None
patent: 03236400 (1991-10-01), None
patent: 6-319537 (1994-11-01), None
patent: WO 86/04145 (1986-07-01), None
patent: WO 95/23165 (1995-08-01), None
patent: WO 96/11953 (1996-04-01), None
patent: 98/55500 (1998-12-01), None
Lissoni et al. Database Caplus, DN 129:298630; European Urology (1997), 31(2), 178-181.
Zink, et al., “Secondary structure of human granulocyte colony-stimulating factor derived from NMR spectroscopy,” pp. 435-439,Elsevier Science Publishers B.V.
Zalipsky, S. Bioconjugate Chem., 6, 150-165.
Arfin et al, PNAS, vol. 92, pp. 7714-7718, Aug. 1995 “Eukaryotic methionyl aminopeptidases: Two classes of cobalt-dependent enzymes”.
Zheng et al, J of Bacteriology, Jun. 2005, p. 3671-3677 “Characterization of Two New Aminopeptidases inEscherichia coli”.
Bregani ER, et al., Recenti Prog Med. Jun. 1995;86(6):231-3 (Abstract).
Eileen M. Lynch, PhD, LE Magazine Jan. 2004, printed from the web Aug. 11, 2005, http://www.alternativehealth.co.nz/emifs.melatoninmain.htm.
McGraw-Hill Dictionary of Scientific and Technical Terms, Fourth Edition, p. 823 (1989).
Bioconjug. Chem., vol. 4, No. 6, (1993) p. 554-559.
Akinaga Shiro
Kobayashi Ken
Konishi Noboru
Maruyama Kumiko
Suzawa Toshiyuki
Borin Michael
Kyowa Hakko Kirin Co., Ltd.
Nixon & Vanderhye P.C.
LandOfFree
Chemically modified polypeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chemically modified polypeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chemically modified polypeptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4144620